Ardelyx ARDX Product sales, net — Cost of Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ardelyx in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ardelyx's product sales, net — cost of sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ardelyx's product sales, net — cost of sales?
- Ardelyx (ARDX) reported product sales, net — cost of sales of $2.88M in Q1 2026.
- How has Ardelyx's product sales, net — cost of sales changed year-over-year?
- Ardelyx's product sales, net — cost of sales increased by 22.9% year-over-year, from $2.34M to $2.88M.
- What does product sales, net — cost of sales mean?
- This metric represents the direct costs incurred to manufacture and deliver the pharmaceutical products sold during the reporting period. It includes expenses such as raw materials, manufacturing labor, and distribution costs directly attributable to product sales. Analyzing this figure provides insight into the company's gross margin efficiency and the scalability of its commercial operations.